Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07281287 · ClinicalTrials.gov registry record · NA
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
A NA study of Oncology and Financial Toxicity, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07281287: Recruiting NA study of Oncology and Financial Toxicity, sponsored by University of Alabama at Birmingham.
NCT07281287 is a NA study of Oncology and Financial Toxicity that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 526-participant average among 24 other Oncology trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07281287, a NA study of Oncology and Financial Toxicity, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are: 1. How did oncology financial navigation implementation strategies affect implementation outcomes? 2. What is the impact of financial navigation on patient financial hardship, quality of life, and psychological distress? 3. How were implementation strategies utilized to overcome barriers to oncology financial navigation? Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.
Primary Outcome
Change in patient-reported financial distress (COmprehensive Score for financial Toxicity)
Conditions Studied
Interventions
- BEHAVIORAL Financial navigation
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT07281287 shows while recruiting
NCT07281287 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 526-participant average among 24 other Oncology trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Oncology appearing as the primary indexed condition, and to 1 intervention - of which Financial navigation is the first listed.
NCT07281287 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT07281287 about?
NCT07281287 is a clinical study titled "Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation". The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are: 1. How did oncology financial navigation implementation strategies affect implementation outcomes? 2. What is the im...
What is the current status of trial NCT07281287?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-02-01. Estimated completion is 2030-12-31.
What conditions does trial NCT07281287 study?
This clinical trial studies the following conditions: Oncology, Financial Toxicity, Counseling.
What interventions are being tested in trial NCT07281287?
The interventions under investigation include: Financial navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07281287?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07281287 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oncology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07281287's enrollment target sits among peer trials
40 19th of 24 higher than 5 of 24 other Oncology trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oncology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Leading Healthy Eating and Activity Promotion Program
RECRUITING · NA
-
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
RECRUITING · NA
-
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
RECRUITING · NA
-
Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI